Allogeneic bone marrow transplantation for low-grade lymphoma and chronic lymphocytic leukemia

Bone Marrow Transplantation

Volumn 25, Issue 6, 2000, Pages 605-612

  Toze, C L ^a,b   Shepherd, J D ^a   Connors, J M ^a   Voss, N J ^a   Gascoyne, R D ^a   Hogge, D E ^a   Klingemann, H G ^a   Nantel, S H ^a   Nevill, T J ^a   Phillips, G L ^a   Reece, D E ^a   Sutherland, H J ^a   Barnett, M J ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b VANCOUVER HOSPITAL AND HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Allogeneic bone marrow transplantation; Chronic lymphocytic leukemia; Low grade lymphoma

Indexed keywords

BUSULFAN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETOPOSIDE; MELPHALAN; METHOTREXATE; METHYLPREDNISOLONE; THIOTEPA; THYMOCYTE ANTIBODY; XOMAZYME;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CLINICAL TRIAL; FEASIBILITY STUDY; FEMALE; GASTROINTESTINAL SYMPTOM; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; LUNG HEMORRHAGE; LYMPHOMA; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; WHOLE BODY RADIATION;

EID: 0034021830     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702191     Document Type: Article

References (62)

1. Horning SJ, Rosenberg SJ. The natural history of initially untreated low-grade non-Hodgkin's lymphomas. New Engl J Med 1984; 311: 1471-1475.
2. Johnson PWM, Rohatiner AZS, Whelan JS et al. Patterns of survival in patients with recurrent follicular lymphoma: a 20-year study from a single center. J Clin Oncol 1995; 13: 140-147.
3. Rai KR, Sawitsky A, Cronkite EP et al. Clinical staging of chronic lymphocytic leukemia. Blood 1975; 46: 219-234.
4. Binet JL, Auquier A, Dighiero G et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 1981; 48: 198-206.
5. Montserrat E, Gomis F, Vallespi T et al. Presenting features and prognosis of chronic lymphocytic leukemia in younger adults. Blood 1991; 78: 1545-1551.
6. Lister TA, Cullen MH, Beard MEJ et al. Comparison of combined and single-agent chemotherapy in non-Hodgkin's lymphoma of favourable histological type. Br Med J 1978; 1: 533-537.
7. Longo DL, Young RC, Hubbard SM et al. Prolonged initial remission in patients with nodular mixed lymphoma. Ann Intern Med 1984: 100: 651-656.
8. Sawitsky A, Rai KR, Glidewell O, Silver RT. Comparison of daily versus intermittent chlorambucil and prednisone therapy in the treatment of patients with chronic lymphocytic leukemia. Blood 1977; 50: 1049-1059.
9. French Cooperative Group on Chronic Lymphocytic Leukemia. A randomized clinical trial of chlorambucil versus COP in stage B chronic lymphocytic leukemia. Blood 1990; 75: 1422-1425.
10. Solal-Celigny P, Lepage E, Brousse N et al. Recombinant interferon alfa-2b combined with a regimen containing doxorubicin in patients with advanced follicular lymphoma. New Engl J Med 1993; 329: 1608-1614.
11. Zinzani DL, Lauria F, Rondelli D et al. Fludarabine: an active agent in the treatment of previously treated and untreated low-grade non-Hodgkin's lymphoma. Ann Oncol 1993; 4: 575-578.
12. Saven A, Emanuele S, Kosty M et al. 2-chlorodeoxyadenosine activity in patients with untreated, indolent non-Hodgkin's lymphoma. Blood 1995; 86: 1710-1716.
13. Keating MJ, Kantarjian H, Talpaz M et al. Fludarabine: a new agent with major activity against chronic lymphocytic leukemia. Blood 1989: 74: 19-25.
14. Saven A, Lemon RH, Kosty M et al. 2-chlorodeoxyadenosine activity in patients with untreated chronic lymphocytic leukemia. J Clin Oncol 1995; 13: 570-574.
15. Glick JH, Barnes JM, Ezdinli EZ et al. Nodular mixed lymphoma: results of a randomized trial failing to confirm prolonged disease-free survival with COPP chemotherapy. Blood 1981; 58: 920-925.
16. Karmiris T, Rohatiner AZS, Love S et al. The management of chronic lymphocytic leukemia at a single centre over a 24-year period: prognostic factors for survival. Hematol Oncol 1994; 12: 29-39.
17. Weisdorf DJ, Andersen JW, Glick JH, Oken MM. Survival after relapse of low-grade non-Hodgkin's lymphoma: implications for marrow transplantation. J Clin Oncol 1992; 10: 942-947.
18. Rodriguez MA, Cabanillas FC, Velasquez W et al. Results of a salvage treatment program for relapsing lymphoma: MINE consolidated with ESHAP. J Clin Oncol 1995; 13: 1734-1741.
19. O'Brien S, Kantarjian H, Estey E et al. Lack of effect of 2-chlorodeoxyadenosine therapy in patients with chronic lymphocytic leukemia refractory to fludarabine therapy. New Engl J Med 1994; 330: 319-322.
20. Seymour JF, Robertson LE, O'Brien S et al. Survival of young patients with chronic lymphocytic leukemia failing fludarabine therapy: a basis for the use of myeloablative therapies. Leuk Lymphoma 1995; 18: 493-496.
21. Jones RJ, Ambinder RF, Piantadosi S, Santos GW. Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation. Blood 1991; 77: 649-653.
22. Ratanatharathorn V, Uberti J, Karanes C et al. Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patients with non-Hodgkin's lymphoma. Blood 1994; 84: 1050-1055.
23. Jarque I, Palau J, Sanz GF et al. Delayed complete response after allogeneic bone marrow transplantation in chronic lymphocytic leukemia (letter). Blood 1993; 82: 1036-1038.
24. Mehta J, Powles R, Singhal S et al. Clinical and hematologic response of chronic lymphocytic and prolymphocytic leukemia persisting after allogeneic bone marrow transplantation with the onset of acute graft-versus-host disease: possible role of graft-versus-leukemia. Bone Marrow Transplant 1996; 17: 371-375.
25. Rondon G, Giralt S, Huh Y et al. Graft-versus-leukemia effect after allogeneic bone marrow transplantation for chronic lymphocytic leukemia. Bone Marrow Transplant 1996; 18: 669-672.
26. Demagalhaes-Silverman M, Donnenberg A, Hammert L et al. Induction of graft-versus-leukemia effect in a patient with chronic lymphocytic leukemia. Bone Marrow Transplant 1997; 20: 175-177.
27. Lundberg JH, Hansen RM, Chitambar CR et al. Allogeneic bone marrow transplantation for relapsed and refractory lymphoma using genotypically HLA-identical and alternative donors. J Clin Oncol 1991; 9: 1848-1859.
28. Shepherd JD, Barnett MJ, Connors JM et al. Allogeneic bone marrow transplantation for poor-prognosis non-Hodgkin's lymphoma. Bone Marrow Transplant 1993; 12: 591-596.
29. Van Besien W, Khouri IF, Giralt SA et al. Allogeneic bone marrow transplantation for refractory and recurrent low-grade lymphoma: the case for aggressive management. J Clin Oncol 1995; 13: 1096-1102.
30. Martinez C, Martino R, Brunet S et al. Allogeneic stem cell transplantation for advanced low-grade lymphoproliferative disorders: report of six cases. Haematologica 1996; 81: 330-334.
31. Van Besien K, Mehra RC, Giralt SA et al. Allogeneic bone marrow transplantation for poor-prognosis lymphoma: response, toxicity, and survival depend on disease histology. Am J Med 1996; 100: 299-307.
32. Verdonck LF, Dekker AW, Lokhorst HM et al. Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin's lymphoma. Blood 1997; 90: 4201-4205.
33. Van Besien K, Sobocinski KA, Rowlings PA et al. Allogeneic bone marrow transplantation for low-grade lymphoma. Blood 1998; 92: 1832-1836.
34. Bandini G, Michallet M, Rosti G, Tura S. Bone marrow transplantation for chronic lymphocytic leukemia. Bone Marrow Transplant 1991; 7: 251-253.
35. Michallet M, Corront B, Hollard D et al. Allogeneic bone marrow transplantation in chronic lymphocytic leukemia: 17 cases. Report from the EBMTG. Bone Marrow Transplant 1991; 7: 275-279.
36. Bastion Y, Felman P, Dumontet C et al. Intensive radiochemotherapy with peripheral blood stem cell transplantation in young patients with chronic lymphocytic leukemia. Bone Marrow Transplant 1992; 10: 467-468.
37. Rabinowe SN, Soiffer RJ, Gribben JG et al. Autologous and allogeneic bone marrow transplantation for poor prognosis patients with B-cell chronic lymphocytic leukemia. Blood 1993; 82: 1366-1376.
38. Khouri IF, Keating MJ, Vriesendorp HM et al. Autologous and allogeneic bone marrow transplantation for chronic lymphocytic leukemia: preliminary results. J Clin Oncol 1994; 12: 748-758.
39. Zomas A, Mehta J, Powles R et al. Unusual infections following allogeneic bone marrow transplantation for chronic lymphocytic leukemia. Bone Marrow Transplant 1994; 14: 799-803.
40. Michallet M, Archimbaud E, Bandini G et al. HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukemia. Ann Intern Med 1996; 124: 311-315.
41. Khouri IF, Przepiorka D, Van Besien K et al. Allogeneic blood or marrow transplantation for chronic lymphocytic leukaemia: timing of transplantation and potential effect of fludarabine on acute graft-versus-host disease. Br J Haematol 1997; 97: 466-473.
42. Reece D, Thomas T, Lansdorp P et al. A preliminary analysis of intensified conditioning (IC) followed by transplantation of allogeneic bone marrow (ALLOBMT) depleted of CD3+ cells using high gradient magnetic separation (HGMS) in patients (PTS) receiving unrelated donor (UD) grafts. Blood 1994; 84 (Suppl. 1): 342a (Abstr.).
43. Byers VS, Henslee PJ, Kernan NA et al. Use of an anti-pan T-lymphocyte ricin A chain immunotoxin in steroid-resistant acute graft-versus-host disease. Blood 1990; 75: 1426-1432.
44. Cuthbert RJG, Phillips GL, Barnett MJ et al. Anti-interleukin-2 receptor monoclonal antibody (BT 563) in the treatment of severe acute GVHD refractory to systemic corticosteroid therapy. Bone Marrow Transplant 1992; 10: 451-455.
45. Deeg HJ, Loughran JR TP, Storb R et al. Treatment of human acute graft-versus-host disease with antithymocyte globulin and cyclosporine with or without methylprednisolone. Transplantation 1985; 40: 162-166.
46. Attal M, Huguet F, Rubie H et al. Prevention of hepatic veno-occlusive disease after bone marrow transplantation by continuous infusion of low-dose heparin: a prospective, randomized trial. Blood 1992; 79: 2834-2840.
47. Bearman SI, Applebaum FR, Buckner CD et al. Regimen-related toxicity in patients undergoing bone marrow transplantation. J Clin Oncol 1988; 6: 1562-1568.
48. Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295-304.
49. Weisdorf DJ, Snover DC, Haake R et al. Acute upper gastrointestinal graft-versus-host disease: clinical significance and response to immunosuppressive therapy. Blood 1990; 76: 624-629.
50. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
51. Cox DR. Regression models and life tables. J R Stat Soc (B) 1972; 34: 187-220.
52. Pangalis GA, Reverter JC, Boussiotis VA, Montserrat E. Chronic lymphocytic leukemia in younger adults: preliminary results of a study based on 454 patients - IWCLL/working group. Leak Lymphoma 1991; 5 (Suppl.): 175-178.
53. Martino R, Brunet S, Garcia A et al. Various patterns of chimerism after allogeneic bone marrow transplantation for advanced chronic lymphocytic leukemia. Bone Marrow Transplant 1995; 16: 783-786.
54. Provan D, Bartlett-Pandite L, Zwicky C et al. Eradication of polymerase chain reaction-detectable chronic lymphocytic leukemia cells is associated with improved outcome after bone marrow transplantation. Blood 1996; 88: 2228-2235.
55. Bird JM, Russell NH, Samson D. Minimal residual disease after bone marrow transplantation for multiple myeloma: evidence for cure in long-term survivors. Bone Marrow Transplant 1993; 12: 651-654.
56. Freedman AS, Ritz J, Neuberg D et al. Autologous bone marrow transplantation in 69 patients with a history of low-grade B-cell non-Hodgkin's lymphoma. Blood 1991; 77: 2524-2529.
57. Rohatiner AZS, Johnson PWM, Price CGA et al. Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma. J Clin Oncol 1994; 12: 1177-1184.
58. Johnson PWM, Price CGA, Smith T et al. Detection of cells bearing the t(14;18) translocation following myeloablative treatment and autologous bone marrow transplantation for follicular lymphoma. J Clin Oncol 1994; 12: 798-805.
59. Bierman PJ, Vose JM, Anderson JR et al. High-dose therapy with autologous hematopoietic rescue for follicular low-grade Non-Hodgkin's lymphoma. J Clin Oncol 1997; 15: 445-450.
60. Mehta J, Powles R, Singhal S et al. Antimicrobial prophylaxis to prevent opportunistic infections in patients with chronic lymphocytic leukemia after allogeneic blood or marrow transplantation. Leuk Lymphoma 1997; 26: 83-88.
61. Khouri IF, Keating M, Korbling M et al. Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies. J Clin Oncol 1998; 16: 2817-2824.
62. Press OW, Eary JF, Appelbaum FR et al. Phase II trial of 1311-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas. Lancet 1995; 346: 336-340.